Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea
NCT01797809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 757
Last updated 2019-04-09
Summary
The objective of this PMS is to gain information about safety and efficacy in real practice as a regulatory commitment required by KFDA (Korea Food and drug administration)
Conditions
- Contraception
Interventions
- DRUG
-
EV/DNG (Qlaira, BAY86-5027)
Patients in daily life clinical practice tratment receiving Qlaira according to indication on the label.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-11
- Primary Completion
- 2018-01-16
- Completion
- 2018-05-08
Countries
- South Korea
More Related Trials
-
Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects
NCT01638910 ·Status: COMPLETED ·Phase: PHASE3
-
Yasmin Post Marketing Surveillance
NCT00923572 ·Status: COMPLETED
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects
NCT05677035 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters
NCT00318799 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive
NCT00185224 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
NCT00778609 ·Status: COMPLETED ·Phase: PHASE3
-
Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens
NCT00805415 ·Status: COMPLETED ·Phase: PHASE2
-
KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method
NCT03182140 ·Status: COMPLETED
-
Post Marketing Surveillance Study For Sayana®
NCT02104557 ·Status: COMPLETED
-
Comparative Cycle Control Europe
NCT00185367 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
NCT01257984 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding
NCT01638923 ·Status: COMPLETED ·Phase: PHASE3
-
Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914
NCT00456924 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of SH T00658ID on Libido
NCT00764881 ·Status: COMPLETED ·Phase: PHASE3
-
Mirena Post-marketing Surveillance in Japan
NCT01414140 ·Status: COMPLETED
-
This Study Tests in Healthy Korean Women Which Effects BI 409306 and a Birth-control Pill Have on Each Other
NCT03193307 ·Status: COMPLETED ·Phase: PHASE1
-
Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
NCT01590537 ·Status: COMPLETED
-
DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.
NCT01731132 ·Status: COMPLETED
-
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
NCT00261482 ·Status: COMPLETED ·Phase: PHASE4
-
GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China
NCT00884260 ·Status: COMPLETED ·Phase: PHASE3
-
Birth Control Patch Study
NCT00984789 ·Status: COMPLETED ·Phase: PHASE3
-
HR-QoL and Sexuality in Mirena Inserted Contraception Users
NCT00498784 ·Status: COMPLETED ·Phase: PHASE4
-
Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
NCT07248046 ·Status: RECRUITING
-
Post-marketing, Observational Study to Confirm the Safety and Efficacy of MARVELON (Study P06083)
NCT01005056 ·Status: COMPLETED
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3